$432,416,292
to LEIDOS BIOMEDICAL RESEARCH INC
NCI OPERATIONAL TASK ORDER
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Operational support and task order work for the National Cancer Institute, an ongoing contract that began in 2019.
NCI operations contracts fund critical infrastructure for U.S. cancer research coordination, clinical trials, and data management across the national research enterprise.
Leidos Biomedical Research serves as a backbone contractor for NCI operations; this modification sustains staffing, IT systems, and administrative capacity for downstream academic and industry research partners.
NCI research operations support U.S. leadership in oncology innovation and clinical trial networks, areas where China is rapidly expanding biomedical R&D investment.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-21. Cost: $0.002999.
- 2026-04-30NCI OPERATIONAL TASK ORDER, FY26-FY27$327.1M
- 2026-03-26NIAID COVID-19 ACTIV3$233.6M
- 2026-05-11MD NET$163.5M
- 2026-03-06ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)$141.7M
- 2026-04-09CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM$42.1M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75N91019F00129_7529_75N91019D00024_7529.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.